Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

7,258 total articles

Comfort Systems USA Executive Executes $2.25 Million Stock Sale

Comfort Systems USA Executive Executes $2.25 Million Stock Sale

In a recent filing, it was disclosed that Julie Shaeff, the Chief Accounting Officer for Comfort Systems USA Inc. (NASDAQ: FIX), executed a sale of company stock totaling approximately $2.25 million. The transaction occurred on May 11, 2026, involving the sale of 1,123 shares of common stock at an average price per share of $2,000.37. Following thi…

DHI Group Director Executes Stock Sale Amid Year-to-Date Rally

DHI Group Director Executes Stock Sale Amid Year-to-Date Rally

Joseph G. Massaquoi Jr., a director at DHI Group, Inc. (NASDAQ: DHX), has completed a sale of common stock totaling $82,227. The transaction, which involved 26,611 shares, was executed on May 8, 2026. This divestment occurs against a backdrop of significant price appreciation for the company's stock throughout the current year and follows a period …

Castle Biosciences CEO Executes Rule 10b5-1 Transactions Involving Stock Sales and Option Exercises

Castle Biosciences CEO Executes Rule 10b5-1 Transactions Involving Stock Sales and Option Exercises

Derek Maetzold, the President and Chief Executive Officer of Castle Biosciences Inc. (NASDAQ: CSTL), completed a series of stock transactions on May 7, 2026. These transactions, which were conducted under a pre-established Rule 10b5-1 trading plan adopted in December 2025, involved both the sale of common stock and the acquisition of shares through…

Avalo Therapeutics CFO Executes Stock Transactions via 10b5-1 Plan

Avalo Therapeutics CFO Executes Stock Transactions via 10b5-1 Plan

Christopher Ryan Sullivan, the Chief Financial Officer of Avalo Therapeutics, Inc. (NASDAQ: AVTX), has completed a series of transactions involving the company's common stock. According to a Form 4 filing submitted to the Securities and Exchange Commission on May 11, 2026, these movements were conducted under a Rule 10b5-1 trading plan that Sulliva…

SPS Commerce Director Executes Rule 10b5-1 Stock Transactions

SPS Commerce Director Executes Rule 10b5-1 Stock Transactions

SPS Commerce Inc. (NASDAQ: SPSC) director Marty M. Reaume conducted a series of equity transactions on May 7, 2026, involving both the exercise of stock options and the subsequent sale of common stock. These activities were executed under a pre-arranged Rule 10b5-1 trading plan that had been established on September 10, 2025. The movements occurred…

Eversource Energy Trustee W. Robert Mudge Increases Stake via IRA

Eversource Energy Trustee W. Robert Mudge Increases Stake via IRA

W. Robert Mudge, a member of the Board of Trustees for Eversource Energy (NYSE: ES), has expanded his position in the utility provider through an indirect purchase of common shares. The transaction occurred on May 8, 2026, involving the acquisition of 750 shares at a price point of $66.485 per share. This specific buy represents a total investment …

Rambus Director Necip Sayiner Executes $1.28 Million Stock Sale

Rambus Director Necip Sayiner Executes $1.28 Million Stock Sale

Necip Sayiner, a member of the board of directors at Rambus Inc. (NASDAQ: RMBS), has completed a sale of company shares valued at approximately $1,278,888. The transaction, disclosed in a recent filing with the Securities and Exchange Commission, involves the disposal of 9,824 shares of common stock. This move comes amidst a period of significant p…

UroGen Pharma Chief Medical Officer Executes $300,000 Stock Sale

UroGen Pharma Chief Medical Officer Executes $300,000 Stock Sale

Mark Schoenberg, the Chief Medical Officer at UroGen Pharma Ltd. (NASDAQ:URGN), has completed a sale of 10,000 ordinary shares valued at approximately $300,000. The transactions took place on May 8, 2026, with share prices ranging between $30.00 and $30.05. This divestment was carried out under a Rule 10b5-1 trading plan that had been established b…